OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccine
Roland Tschismarov, Raphaël M. Zellweger, Min Jie Koh, et al.
JCI Insight (2021) Vol. 6, Iss. 21
Open Access | Times Cited: 14
Roland Tschismarov, Raphaël M. Zellweger, Min Jie Koh, et al.
JCI Insight (2021) Vol. 6, Iss. 21
Open Access | Times Cited: 14
Showing 14 citing articles:
Development of Vaccines against Emerging Mosquito-Vectored Arbovirus Infections
Nicola Principi, Susanna Esposito
Vaccines (2024) Vol. 12, Iss. 1, pp. 87-87
Open Access | Times Cited: 9
Nicola Principi, Susanna Esposito
Vaccines (2024) Vol. 12, Iss. 1, pp. 87-87
Open Access | Times Cited: 9
Immunogenicity, safety and duration of protection afforded by chikungunya virus vaccines undergoing human clinical trials
Shambhavi Rao, Daniel Asfaw Erku, Suresh Mahalingam, et al.
Journal of General Virology (2024) Vol. 105, Iss. 2
Closed Access | Times Cited: 5
Shambhavi Rao, Daniel Asfaw Erku, Suresh Mahalingam, et al.
Journal of General Virology (2024) Vol. 105, Iss. 2
Closed Access | Times Cited: 5
The Current Progress in the Quest for Vaccines Against the Semliki Forest Virus Complex
Dorothy H.J. Cheong, Bowen Yi, Yi Hao Wong, et al.
Medicinal Research Reviews (2025)
Closed Access
Dorothy H.J. Cheong, Bowen Yi, Yi Hao Wong, et al.
Medicinal Research Reviews (2025)
Closed Access
Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants
Marc Emmenegger, Sebastian Fiedler, Silvio D. Brugger, et al.
iScience (2022) Vol. 25, Iss. 8, pp. 104766-104766
Open Access | Times Cited: 19
Marc Emmenegger, Sebastian Fiedler, Silvio D. Brugger, et al.
iScience (2022) Vol. 25, Iss. 8, pp. 104766-104766
Open Access | Times Cited: 19
Chikungunya Vaccine Candidates: Current Landscape and Future Prospects
Christin Schmidt, Barbara S. Schnierle
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 3663-3673
Open Access | Times Cited: 16
Christin Schmidt, Barbara S. Schnierle
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 3663-3673
Open Access | Times Cited: 16
Protective Role of NS1-Specific Antibodies in the Immune Response to Dengue Virus Through Antibody-Dependent Cellular Cytotoxicity
Luis A. Sánchez-Vargas, Anuja Mathew, Henrik Salje, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 5, pp. 1147-1156
Closed Access | Times Cited: 2
Luis A. Sánchez-Vargas, Anuja Mathew, Henrik Salje, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 5, pp. 1147-1156
Closed Access | Times Cited: 2
Versatility of live-attenuated measles viruses as platform technology for recombinant vaccines
Aileen Ebenig, Mona V. Lange, Michael D. Mühlebach
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 13
Aileen Ebenig, Mona V. Lange, Michael D. Mühlebach
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 13
Chikungunya vaccines: An update in 2023
Pitchapa Roongaraya, Siwaporn Boonyasuppayakorn
Asian Pacific Journal of Allergy and Immunology (2023)
Open Access | Times Cited: 7
Pitchapa Roongaraya, Siwaporn Boonyasuppayakorn
Asian Pacific Journal of Allergy and Immunology (2023)
Open Access | Times Cited: 7
An overview of anti-Chikungunya antibody response in natural infection and vaccine-mediated immunity, including anti-CHIKV vaccine candidates and monoclonal antibodies targeting diverse epitopes on the viral envelope
Pankaj Chandley, Asha Lukose, Rajesh Kumar, et al.
The Microbe (2023) Vol. 1, pp. 100018-100018
Open Access | Times Cited: 5
Pankaj Chandley, Asha Lukose, Rajesh Kumar, et al.
The Microbe (2023) Vol. 1, pp. 100018-100018
Open Access | Times Cited: 5
Self‐Replicating RNA Viruses for Vaccine Development
Kenneth Lundström
(2024), pp. 109-160
Closed Access | Times Cited: 1
Kenneth Lundström
(2024), pp. 109-160
Closed Access | Times Cited: 1
Recombinant measles virus expressing prefusion spike protein stabilized by six rather than two prolines is more efficacious against SARS‐CoV‐2 infection
Yuexiu Zhang, Mijia Lu, Ilada Thongpan, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Open Access | Times Cited: 3
Yuexiu Zhang, Mijia Lu, Ilada Thongpan, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Open Access | Times Cited: 3
A measles virus-based vaccine induces robust chikungunya virus-specific CD4+ T-cell responses in a phase II clinical trial
Katharina S. Schmitz, Anouskha D. Comvalius, Nella J. Nieuwkoop, et al.
Vaccine (2023) Vol. 41, Iss. 43, pp. 6495-6504
Open Access | Times Cited: 2
Katharina S. Schmitz, Anouskha D. Comvalius, Nella J. Nieuwkoop, et al.
Vaccine (2023) Vol. 41, Iss. 43, pp. 6495-6504
Open Access | Times Cited: 2
Generation of a Live-Attenuated Strain of Chikungunya Virus from an Indian Isolate for Vaccine Development
Sreeja R. Nair, Rachy Abraham, Easwaran Sreekumar
Vaccines (2022) Vol. 10, Iss. 11, pp. 1939-1939
Open Access | Times Cited: 2
Sreeja R. Nair, Rachy Abraham, Easwaran Sreekumar
Vaccines (2022) Vol. 10, Iss. 11, pp. 1939-1939
Open Access | Times Cited: 2
Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies
Teresita Caruso, Francesca Salani, Silvia Catanese, et al.
International Journal of Clinical Oncology (2023) Vol. 28, Iss. 3, pp. 363-369
Open Access
Teresita Caruso, Francesca Salani, Silvia Catanese, et al.
International Journal of Clinical Oncology (2023) Vol. 28, Iss. 3, pp. 363-369
Open Access
